相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
Shengli Xia et al.
LANCET INFECTIOUS DISEASES (2021)
Sputnik V COVID-19 vaccine candidate appears safe and effective Comment
Ian Jones et al.
LANCET (2021)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
Hui Wang et al.
CELL (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer et al.
SCIENCE (2020)
Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans
Gui-Ping Wen et al.
NATURE COMMUNICATIONS (2020)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
E. J. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge
Shipo Wu et al.
NATURE COMMUNICATIONS (2020)
Functional interrogation and mining of natively paired human VH: VL antibody repertoires
Bo Wang et al.
NATURE BIOTECHNOLOGY (2018)
Recombinant human B cell repertoires enable screening for rare, specific, and natively paired antibodies
Saravanan Rajan et al.
COMMUNICATIONS BIOLOGY (2018)
Sequencing and cloning of antigen-specific antibodies from mouse memory B cells
Lotta von Boehmer et al.
NATURE PROTOCOLS (2016)
Manufacturing immunity to disease in a test tube: The magic bullet realized
Richard A. Lerner
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)